SPY334.19+5.46 1.66%
DIA275.90+4.20 1.55%
IXIC11,117.53+203.96 1.87%

Mustang Bio shares are trading higher after the company announced a rare pediatric disease designation for its MB-107 for the treatment of X-linked severe combined immunodeficiency.

Benzinga · 08/17/2020 17:50